The FY18 Defense Appropriation provides $30 million (M) to the Department of Defense Spinal Cord Injury Research Program (SCIRP) to support innovative, high-impact spinal cord injury research. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency, J9 Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Materiel Command (USAMRMC).

FY18 SCIRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.

For FY18, SCIRP encourages applications that address the critical needs of SCI research and patient care in one or more of the following FY18 Focus Areas:

*             Neuroprotection

*             Biomarkers

*             Bladder and bowel dysfunction and neuropathic pain

*             Psychosocial issues relevant to SCI in individuals with SCI and their caregivers

*             Rehabilitation and regeneration

http://cdmrp.army.mil/funding/scirp

Clinical Trial Award – Preproposal due July 9, 2018

Independent investigators at all academic levels (or equivalent)

*         Preproposal is required; application submission is by invitation only.

*             Fund Phase 0, I, or II clinical trials with the potential to have a major impact on treatment or management of spinal cord injury (SCI) and its consequences.

*             Preclinical data required for all clinical trial applications.

*         Maximum funding of $3M for direct costs (plus indirect costs)

*             Maximum period of performance is 4 years

Investigator-Initiated Research Award – Preproposal due July 9, 2018

Independent investigators at all academic levels (or equivalent)

*         Preproposal is required; application submission is by invitation only.

*         Fund SCI-related research that has the potential to make an important contribution to SCI research and/or patient care.

*         Preliminary data required.

*         Clinical trials not allowed.

*         Maximum funding of $500,000 for direct costs (plus indirect costs)

*         Maximum period of performance is 3 years.

Qualitative Research Award – Preproposal due July 9, 2018

Independent investigators at all academic levels (or equivalent)

*         Preproposal is required; application submission is by invitation only.

*         Fund qualitative research on military Service members and Veterans in the years following SCI.

*         Qualitative research is defined as a form of social inquiry that focuses on understanding the way that people interpret and make sense of their experiences and the world in which they live (i.e., seek to understand the human experience).

*         Preliminary data encouraged, but not required.

*         Clinical trials not allowed.

*         Maximum funding of $500,000 for direct costs (plus indirect costs)

*         Maximum period of performance is 3 years

Translational Research Award – Preproposal due July 9, 2018

Independent investigators at all academic levels (or equivalent)

*         Preproposal is required; application submission is by invitation only.

*         Fund studies that accelerate the movement of promising ideas in SCI research into clinical applications.

*         Preliminary data required

*         The SCIRP TRA may include a pilot clinical trial as part of the proposed research where limited clinical testing of a novel intervention or device is necessary to inform the next step in the continuum of translational research.

*         Maximum funding of $1.25M for direct costs (plus indirect costs)

*         Maximum period of performance is 3 years

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRMC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the SCIRP or other CDMRP-administered programs, please visit the CDMRP website   (http://cdmrp.army.mil<http://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk

301-682-5507

help@eBrap.org

The FY18 Defense Appropriations Act provides $10 million (M) to the Department of Defense Hearing Restoration Research Program (HRRP) to support innovative, high-impact hearing restoration research. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA) J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).

FY18 HRRP Program Announcements and General Application Instructions for the following award mechanisms are posted on Grants.gov.

The mission of the HRRP is to advance the science of hearing restoration by delivering groundbreaking research and solutions that remove barriers to the successful treatment of auditory system injury. Applications submitted to the FY18 HRRP must addresses one or more of the following Focus Areas (revised for FY18):

• ·         Develop reliable in vitro human models for evaluating hearing restoration therapies.
• ·         Accelerate translation of biological regeneration mechanisms into therapies that restore auditory function.
• ·         Develop and or validate techniques/methods to assess and or treat auditory dysfunction as related to synaptopathy, hidden hearing loss, and central auditory processing disorders.

http://cdmrp.army.mil/funding/hrrp

Translational Research Award (TRA) – Preproposal due July 17, 2018

• ·         Independent investigators at all academic levels (or equivalent)
• ·         Preproposal is required; application submission is by invitation only.
• ·         Supports animal and human studies to:
• ·         develop reliable in vitro human models for evaluating hearing restoration therapies, or
• ·         Accelerate translation of biological regeneration into therapies that restore auditory function, including, for example, synaptic plasticity and hair cell and neural regeneration.
• ·         Preliminary data required.
• ·         Clinical trials are not allowed.

• Maximum funding of $1M for direct costs (plus indirect costs)
• Maximum period of performance is 3 years

Focused Research Award (FRA) – Preproposal due July 17, 2018

• ·         Independent investigators at all academic levels (or equivalent)
• ·         Preproposal is required; application submission is by invitation only.
• ·         Supports animal and human studies to develop and/or validate techniques and/or methods to assess and/or treat auditory dysfunction as related to synaptopathy, hidden hearing loss, and central auditory processing disorders. Examples include:

-       field tool(s) to diagnose hidden hearing loss and to inform operational readiness;

-       batteries of differential diagnostics tests that pinpoint the location(s) of auditory damage;

-       treatments for the various types of damage that result in the loss of hearing leading to decreased operational readiness.

• ·         Preliminary data required.
• ·         Clinical trials are not allowed.
• ·         Maximum period of performance is 3 years

• Maximum funding of $1M for direct costs (plus indirect costs)

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

Extramural applications must be submitted through the federal government’s single-entry portal, Grants.gov. For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the HRRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk 
301-682-5507 
help@eBrap.org

What is this prize?

The Killam Prizes are awarded to active Canadian scholars who have made a substantial and significant contribution to their respective fields in the humanities, social sciences, natural sciences, health sciences or engineering.

Prize amount

Up to five prizes of $100,000 each (one prize per discipline)

How to qualify

Nominations must be submitted to the Council by an expert in the same field as the nominee.

A peer assessment committee will select the recipients from among all nominees.

Read the Killam Prizes Guidelines for eligibility criteria and the nomination form.

Visit the Killam Program website for more information on the Killam Prizes.

SSHRC, in conjunction with Immigration, Refugees and Citizenship Canada (IRCC), is launching a funding opportunity to support Canadian engagement with European research partners.

This builds on a session on existing and potential research collaboration between Canadian and European experts that was cohosted by SSHRC and the European Union (EU) at the 2018 National Metropolis Conference.

Horizon 2020 (H2020) is the EU’s largest research funding platform to date. In October 2017, the EU released the platform’s final work program for 2018-20 that comprises calls for research worth €30 billion.

The platform includes an ambitious plan for international research collaboration on migration issues, with up to €71 million in budget years 2018 and 2019 for topics ranging from the international protection of refugees to the integration of migrant children.

SSHRC encourages interested Canadian researchers to work directly with research teams from EU member states on the theme of Migration within Horizon 2020 Societal Challenge 6: Europe in a changing world— Inclusive, innovative and reflective societies. SSHRC and IRCC will make one- to three-year awards valued at $75,000 to $200,000 available to researchers affiliated with an eligible Canadian institution on successful H2020 research teams.

Researchers based in Quebec may receive additional support of $50,000 from the Fonds de recherche du Québec - Société et culture (FQRSC) program: Soutien à des initiatives internationales de recherche et d'innovation (SIIRI) - PSR (volet 4).

For further details about the call, visit the European Commission’s Research & Innovation Participant Portal.

The EU is responsible for the merit review of the full consortium proposals and funding recommendations. To fund activities by Canadians within the consortiums, SSHRC will require submission of a reduced set of application materials from Canadian participants demonstrating institutional, participant and subject matter eligibility for SSHRC funding, brief project descriptions and a budget for Canadian activities.

Detailed instructions about the SSHRC application for Canadian researchers will be available in early summer 2018.

SSHRC will co-fund the following four subthemes for 2018-19:

The Discovery Grants Program assists in:

• promoting and maintaining a diversified base of high-quality research capability in the natural sciences and engineering in Canadian universities;
• fostering research excellence; and
• providing a stimulating environment for research training.

The specific objectives of the Team Grant: Pathways Implementation Research Team Component 3 funding opportunity are to:

• Increase the equitable reach, access and sustainability of culturally appropriate population health interventions using an implementation science approach
• Develop and share recommendations, guidelines and policies for sustainability and enhanced equitable reach and access of interventions that incorporate reciprocal learning between participating Indigenous communities and research teams
• Build capacity for implementation research in Indigenous communities by training and mentoring junior researchers through partnerships with communities, including students and trainees with Indigenous living experience, and community members

The Team Grant: HIV/AIDS Biomedical Clinical Research funding opportunity is expected to contribute to the global search for a safe and effective cure for HIV, and to develop prevention strategies and tools.

The specific objectives of this funding opportunity are to:

• transform HIV biomedical and clinical research in Canada into a collaborative, interdisciplinary model of knowledge creation and application through the funding of innovative research programs;
• create an inclusive and sustainable pipeline of HIV research capacity from across disciplines, sectors, and perspectives (e.g., HIV basic scientists, clinical investigators, knowledge users and/or community members [people living with HIV]);
• effectively translate knowledge into clinical and/or commercial applications which contribute to the design, development and evaluation of research strategies; and
• create a critical mass of technical and scientific expertise in Canada that engages meaningfully with one another and with relevant national stakeholders, and participates in international research efforts.